Promethium Advisors,Llc Merck & Co., Inc. Transaction History
Promethium Advisors,Llc
- $174 Billion
- Q3 2025
A detailed history of Promethium Advisors,Llc transactions in Merck & Co., Inc. stock. As of the latest transaction made, Promethium Advisors,Llc holds 6,728 shares of MRK stock, worth $624,762. This represents 0.33% of its overall portfolio holdings.
Number of Shares
6,728
Previous 6,728
-0.0%
Holding current value
$624,762
Previous $538 Million
5.96%
% of portfolio
0.33%
Previous 0.33%
Shares
4 transactions
Others Institutions Holding MRK
# of Institutions
3,881Shares Held
1.9BCall Options Held
30.1MPut Options Held
27.7M-
Vanguard Group Inc Valley Forge, PA252MShares$23.4 Billion0.33% of portfolio
-
Black Rock Inc. New York, NY207MShares$19.2 Billion0.59% of portfolio
-
State Street Corp Boston, MA118MShares$11 Billion0.35% of portfolio
-
Wellington Management Group LLP Boston, MA75.3MShares$6.99 Billion1.16% of portfolio
-
Geode Capital Management, LLC Boston, MA59.8MShares$5.55 Billion0.33% of portfolio
About Merck & Co., Inc.
- Ticker MRK
- Exchange NYSE
- Sector Healthcare
- Industry Drug Manufacturers—General
- Shares Outstandng 2,533,280,000
- Market Cap $235B
- Description
- Merck & Co., Inc. operates as a healthcare company worldwide. It operates through two segments, Pharmaceutical and Animal Health. The Pharmaceutical segment offers human health pharmaceutical products in the areas of oncology, hospital acute care, immunology, neuroscience, virology, cardiovascular, and diabetes, as well as vaccine products, ...